monoclonal antibodies - Bioprocess Development Forum

Articles BioPharma

July 13, 2023

While the biopharma industry is pushing the barriers with antibody development, it must also contend…

admin-element

Articles Downstream

June 13, 2023

Continued development of new and next-generation antibodies is spurred by the increasing demand for more…

admin-element

Articles Downstream

May 19, 2023

Antibody therapeutics are the largest class of biotherapeutics. Over the years, development...

admin-element

Articles Upstream

October 21, 2021

Doing cell culture and upstream process development on antibodies, vaccines, or viruses?

admin-element

Articles Downstream Regulatory Upstream

November 5, 2020

Drug development is undergoing a transformation from multi-billion-dollar blockbusters to personalized...

admin-element

Articles BioPharma Downstream Upstream

January 31, 2019

Ensuring the stability of biotherapeutic products, which has an impact on their safety and...

admin-element

Articles BioPharma Regulatory

July 18, 2014

A critical quality attribute (CQA) has been defined as “a physical, chemical, biological...

admin-element